Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.

Article date: 1981/9/25

PubMed ID: 1172258

Journal name: Molecular and cellular biochemistry (ISSN: 0300-8177)


Author List: Gale K, Casu M

Publication Types: Journal Article; Review

Substances mentioned in the article: Aminocaproates; Dopamine Antagonists; GABA Antagonists; Receptors, Cell Surface; Receptors, Dopamine; Receptors, GABA-A; Muscimol; Serotonin; gamma-Aminobutyric Acid; Tyrosine 3-Monooxygenase; Glutamate Dehydrogenase; 4-Aminobutyrate Transaminase; Vigabatrin; Chlorpromazine; Dopamine;

Mesh terms: 4-Aminobutyrate Transaminase/metabolism; Afferent Pathways/physiology; Aminocaproates/pharmacology; Animals; Basal Ganglia/physiology; Behavior, Animal/drug effects; Brain/drug effects; Chlorpromazine/pharmacology; Corpus Striatum/physiology; Dopamine/physiology; Dopamine Antagonists; Dyskinesia, Drug-Induced/physiopathology; Efferent Pathways/physiology; GABA Antagonists; Glutamate Dehydrogenase/metabolism; Humans; Huntington Disease/physiopathology; Muscimol/pharmacology; Neurons/physiology; Rats; Receptors, Cell Surface/metabolism; Receptors, Dopamine/physiology; Receptors, GABA-A; Schizophrenia/drug therapy; Serotonin/metabolism; Substantia Nigra/physiology; Synapses/physiology; Synaptic Transmission; Tyrosine 3-Monooxygenase/metabolism; Vigabatrin; gamma-Aminobutyric Acid/physiology;

Citations: - 4153770

1172258.txt ยท Last modified: 2018/11/20 14:26 (external edit)